Reference

CEM/CMO/2021/004

Name

COVID-19 therapeutic alert: interleukin-6 inhibitors (tocilizumab or sarilumab) for critically ill patients with COVID-19 pneumonia (adults)

Categories

Scottish Government Drug Alerts

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND DRUGS SAFETY RISKS PHARMACEUTICAL INDUSTRY DRUG THERAPY PHARMACEUTICAL SERVICES

Description

Attaches a letter about the UK Interim Clinical Commissioning Policies which have now been published, recommending that two Interleukin-6 (IL-6) inhibitors – tocilizumab and sarilumab - are made available as a treatment option for critically ill adult patients (aged 18 years and over) hospitalised with COVID-19 in accordance with the agreed criteria.

Contact Name

Contact Email

Contact Address

Contact Phone

Created

2021-02-01 00:00:00

Download URL